REFERENCES
- Agbulut O, Destombes J, Thiesson D, Butler-Browne G. 2000. Age-related appearance of tubular aggregates in the skeletal muscle of almost all male inbred mice. Histochem Cell Biol. 114(6):477–481.
- Andres-Lacueva C, Macarulla MT, Rotches-Ribalta M, Boto-Ordonez M, Urpi-Sarda M, Rodriguez VM, Portillo MP. 2012. Distribution of resveratrol metabolites in liver, adipose tissue, and skeletal muscle in rats fed different doses of this polyphenol. J Agric Food Chem. 60(19):4833–4840.
- Ballak SB, Buse-Pot T, Harding PJ, Yap MH, Deldicque L, de Haan A, Jaspers RT, Degens H. 2016. Blunted angiogenesis and hypertrophy are associated with increased fatigue resistance and unchanged aerobic capacity in old overloaded mouse muscle. Age (Dordr). 38(2):39.
- Barnouin Y, McPhee JS, Butler-Browne G, Bosutti A, De Vito G, Jones DA, Narici M, Behin A, Hogrel JY, Degens H. 2017. Coupling between skeletal muscle fiber size and capillarization is maintained during healthy aging. J Cachexia Sarcopenia Muscle. 8(4):647–659.
- Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, et al. 2006. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 444(7117):337–342.
- Bosutti A, Degens H. 2015. The impact of resveratrol and hydrogen peroxide on muscle cell plasticity shows a dose-dependent interaction. Sci Rep. 5(1):8093.
- Bresciani L, Calani L, Bocchi L, Delucchi F, Savi M, Ray S, Brighenti F, Stilli D, Del Rio D. 2014. Bioaccumulation of resveratrol metabolites in myocardial tissue is dose-time dependent and related to cardiac hemodynamics in diabetic rats. Nutr Metab Cardiovasc Dis. 24(4):408–415.
- Breuss JM, Atanasov AG, Uhrin P. 2019. Resveratrol and its effects on the vascular system. Int J Mol Sci. 20(7):1523.
- Chen Y, Tseng SH. 2007. Pro- and anti-angiogenesis effects of resveratrol. In Vivo. 21(2):365–370.
- Chevessier F, Marty I, Paturneau-Jouas M, Hantai D, Verdiere-Sahuque M. 2004. Tubular aggregates are from whole sarcoplasmic reticulum origin: alterations in calcium binding protein expression in mouse skeletal muscle during aging. Neuromuscul Disord. 14(3):208–216.
- Desquiret-Dumas V, Gueguen N, Leman G, Baron S, Nivet-Antoine V, Chupin S, Chevrollier A, Vessieres E, Ayer A, Ferre M, et al. 2013. Resveratrol induces a mitochondrial complex I-dependent increase in NADH oxidation responsible for sirtuin activation in liver cells. J Biol Chem. 288(51):36662–36675.
- Diaz M, Degens H, Vanhees L, Austin C, Azzawi M. 2016. The effects of resveratrol on aging vessels. Exp Gerontol. 85:41–47.
- Dutta S, Sengupta P. 2016. Men and mice: relating their ages. Life Sci. 152:244–248.
- Flurkey K, Mcurrer J, Harrison D. 2007. Mouse models in aging research. In: The mouse in biomedical research. 2nd ed., 637–672. Burlington: Academic Press.
- Giacomello E, Quarta M, Paolini C, Squecco R, Fusco P, Toniolo L, Blaauw B, Formoso L, Rossi D, Birkenmeier C, et al. 2015. Deletion of small ankyrin 1 (sAnk1) isoforms results in structural and functional alterations in aging skeletal muscle fibers. Am J Physiol, Cell Physiol. 308(2):C123–C138.
- Gliemann L, Olesen J, Bienso RS, Schmidt JF, Akerstrom T, Nyberg M, Lindqvist A, Bangsbo J, Hellsten Y. 2014. Resveratrol modulates the angiogenic response to exercise training in skeletal muscles of aged men. Am J Physiol Heart Circ Physiol. 307(8):H1111–H1119.
- Kaga S, Zhan L, Matsumoto M, Maulik N. 2005. Resveratrol enhances neovascularization in the infarcted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor. J Mol Cell Cardiol. 39(5):813–822.
- Kamei M, Isogai S, Pan W, Weinstein BM. 2010. Imaging blood vessels in the zebrafish. Methods Cell Biol. 100:27–54.
- Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, et al. 2006. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 127(6):1109–1122.
- Madreiter-Sokolowski CT, Sokolowski AA, Graier WF. 2017. Dosis Facit Sanitatem-Concentration-dependent effects of resveratrol on mitochondria. Nutrients. 9(10):1117.
- Murase T, Haramizu S, Ota N, Hase T. 2009. Suppression of the aging-associated decline in physical performance by a combination of resveratrol intake and habitual exercise in senescence-accelerated mice. Biogerontology. 10(4):423–434.
- Pearson KJ, Baur JA, Lewis KN, Peshkin L, Price NL, Labinskyy N, Swindell WR, Kamara D, Minor RK, Perez E, et al. 2008. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab. 8(2):157–168.
- Pollack RM, Barzilai N, Anghel V, Kulkarni AS, Golden A, O’Broin P, Sinclair DA, Bonkowski MS, Coleville AJ, Powell D, et al. 2017. Resveratrol improves vascular function and mitochondrial number but not glucose metabolism in older adults. J Gerontol A Biol Sci Med Sci. 72(12):1703–1709.
- Prior SJ, Ryan AS, Blumenthal JB, Watson JM, Katzel LI, Goldberg AP. 2016. Sarcopenia is associated with lower skeletal muscle capillarization and exercise capacity in older adults. Gerona. 71(8):1096–1101.
- Ringholm S, Olesen J, Pedersen JT, Brandt CT, Halling JF, Hellsten Y, Prats C, Pilegaard H. 2013. Effect of lifelong resveratrol supplementation and exercise training on skeletal muscle oxidative capacity in aging mice; impact of PGC-1α. Exp Gerontol. 48(11):1311–1318.
- Rodriguez-Bies E, Tung BT, Navas P, Lopez-Lluch G. 2016. Resveratrol primes the effects of physical activity in old mice. Br J Nutr. 116(6):979–988.
- Rosenberg IH. 1997. Sarcopenia: origins and clinical relevance. J Nutr. 127(5 Suppl):990S–991S.
- Schiaffino S. 2012. Tubular aggregates in skeletal muscle: just a special type of protein aggregates? Neuromuscul Disord. 22(3):199–207.
- Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, et al. 2012. Fiji: an open-source platform for biological-image analysis. Nat Methods. 9(7):676–682.
- Sullivan MJ, Green HJ, Cobb FR. 1990. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation. 81(2):518–527.
- Sun C, Zhang F, Ge X, Yan T, Chen X, Shi X, Zhai Q. 2007. SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab. 6(4):307–319.
- Toniolo L, Fusco P, Formoso L, Mazzi A, Canato M, Reggiani C, Giacomello E. 2018. Resveratrol treatment reduces the appearance of tubular aggregates and improves the resistance to fatigue in aging mice skeletal muscles. Exp Gerontol. 111:170–179.
- Vielhaber S, Schroder R, Winkler K, Weis S, Sailer M, Feistner H, Heinze HJ, Schroder JM, Kunz WS. 2001. Defective mitochondrial oxidative phosphorylation in myopathies with tubular aggregates originating from sarcoplasmic reticulum. J Neuropathol Exp Neurol. 60(11):1032–1040.
- Vitrac X, Desmouliere A, Brouillaud B, Krisa S, Deffieux G, Barthe N, Rosenbaum J, Merillon JM. 2003. Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci. 72(20):2219–2233.
- Wan JJ, Qin Z, Wang PY, Sun Y, Liu X. 2017. Muscle fatigue: general understanding and treatment. Exp Mol Med. 49(10):e384.
- Wu RE, Huang WC, Liao CC, Chang YK, Kan NW, Huang CC. 2013. Resveratrol protects against physical fatigue and improves exercise performance in mice. Molecules. 18(4):4689–4702.